-$0.19 EPS Expected for Keryx Biopharmaceuticals (KERX) This Quarter


Equities analysts predict that Keryx Biopharmaceuticals will announce earnings per share of for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Keryx Biopharmaceuticals' earnings, with the highest EPS estimate coming in at and the lowest estimate coming in at .



from Biotech News